Read + Share
Amedeo Smart
Independent Medical Education
Sarli M, Novoa MB, Mazzucco MN, Signorini ML, et al. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. PLoS One 2020;15:e0229301.PMID: 32084216
Email
LinkedIn
Facebook
Twitter
Privacy Policy